Dr Reddy's Laboratories, one of the leading Indian pharmaceutical companies, has launched Atocor-R (Atorvastatin + Ramipril) in Indian market.

Atocor-R is used in the treatment of patients with both essential hypertension and hypercholesterolemia.

The drug is the first such combination to be approved by the Drugs Controller General of India (DCGI) and has completed a multi-centre clinical trial data on Indian patients.

The new product is available in two fixed dose combinations of Atocor-R 2.5 (Atorvastatin 10 mg + Ramipril 2.5 mg ) and Atocor-R 5 (Atorvastatin 10 mg + Ramipril 5 mg) and comes in pack of 10.

The company’s net profit for the fourth quarter ended March 31, 2008, dipped 39.65 per cent to touch Rs 162.26 crore as compared with Rs 268.9 crore in the corresponding period last year.